|
|
muscle system process
|
GO:0003012 |
141 |
0.868
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.742
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.550
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.518
|
Human |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.488
|
Human |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.472
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.399
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.391
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.364
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.356
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.356
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.352
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.338
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.333
|
Mouse |
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.310
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.308
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.306
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.300
|
Human |
|
|
cell growth
|
GO:0016049 |
130 |
0.299
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.299
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.291
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.285
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.283
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.282
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.274
|
Human |
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.272
|
|
|
|
negative regulation of nucleotide metabolic process
|
GO:0045980 |
16 |
0.268
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.265
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.262
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.257
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.248
|
Mouse |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.247
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.247
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.241
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.238
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.238
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.235
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.234
|
Human |
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.231
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.225
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.225
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.220
|
Human |
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.219
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.219
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.214
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.210
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.208
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.206
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.203
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.203
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.199
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.197
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.196
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.195
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.194
|
Mouse |
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.192
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.191
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.191
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.190
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.186
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.182
|
Human Mouse |
|
|
negative regulation of purine nucleotide biosynthetic process
|
GO:1900372 |
6 |
0.177
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.177
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.173
|
Human |
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.173
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.173
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.168
|
Human |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.167
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.166
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.166
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.163
|
Mouse |
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.162
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.161
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.160
|
Mouse |
|
|
cell junction organization
|
GO:0034330 |
77 |
0.153
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.153
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.153
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.151
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.147
|
Human |
|
|
mapk cascade
|
GO:0000165 |
281 |
0.146
|
Human |
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.146
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.145
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.144
|
Human |
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.144
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.143
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.140
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.140
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.138
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.138
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.137
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.137
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.137
|
Mouse |
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.136
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.135
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.132
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.130
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.129
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.129
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.129
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.127
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.126
|
Human |
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.126
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.125
|
Human |
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.124
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.122
|
Human |
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.122
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.121
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.120
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.119
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.119
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.118
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.117
|
Human |
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.116
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.115
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.113
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.113
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.113
|
Human |
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.112
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.109
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.106
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.106
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.105
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.103
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.101
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.100
|
Mouse |
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.099
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.099
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.099
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.098
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.097
|
|
|
|
negative regulation of cyclic nucleotide metabolic process
|
GO:0030800 |
5 |
0.096
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.095
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.095
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.095
|
|
|
|
enteric smooth muscle cell differentiation
|
GO:0035645 |
1 |
0.094
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.093
|
Human |
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.093
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.092
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.091
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.089
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.089
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.088
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.086
|
Human |
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.086
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.085
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.085
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.085
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.084
|
|
|
|
regulation of dopamine metabolic process
|
GO:0042053 |
10 |
0.084
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.084
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.084
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.084
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.084
|
Human |
|
|
actin filament organization
|
GO:0007015 |
113 |
0.082
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.082
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.081
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.080
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.080
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.079
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.079
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.079
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.079
|
Human |
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.079
|
Human |
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.078
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.078
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.077
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.077
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.076
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.076
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.075
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.075
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.075
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.075
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.074
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.074
|
Mouse |
|
|
response to pain
|
GO:0048265 |
26 |
0.074
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.073
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.073
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.072
|
|
|
|
negative regulation of response to oxidative stress
|
GO:1902883 |
10 |
0.072
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.071
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.071
|
Human |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.069
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.068
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.068
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.068
|
|
|
|
penile erection
|
GO:0043084 |
2 |
0.068
|
|
|
|
temperature homeostasis
|
GO:0001659 |
26 |
0.068
|
Mouse |
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.067
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.067
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.066
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.066
|
Human |
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.066
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.065
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.065
|
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.064
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.064
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.063
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.063
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.062
|
Human |
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.062
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.062
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.061
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.061
|
|
|
|
negative regulation of oxidative stress induced cell death
|
GO:1903202 |
9 |
0.061
|
|
|
|
negative regulation of camp metabolic process
|
GO:0030815 |
5 |
0.061
|
|
|
|
negative regulation of cellular response to oxidative stress
|
GO:1900408 |
10 |
0.061
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.061
|
Mouse |
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.061
|
Human |
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.060
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.060
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.060
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.060
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.059
|
Human |
|
|
positive regulation of reproductive process
|
GO:2000243 |
19 |
0.059
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.059
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.059
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.058
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.058
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.058
|
Human |
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.058
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.058
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.058
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.057
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.057
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.057
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.057
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.057
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.057
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.057
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.056
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.055
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.055
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.055
|
|
|
|
positive regulation of urine volume
|
GO:0035810 |
6 |
0.055
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.055
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.055
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.055
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.055
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.055
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.054
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.053
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.053
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.052
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.052
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.052
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.051
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.051
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.051
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.051
|
Human |
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.050
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.050
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.050
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.049
|
|
|
|
negative regulation of camp biosynthetic process
|
GO:0030818 |
5 |
0.049
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.049
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.049
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.049
|
|
|
|
regulation of excretion
|
GO:0044062 |
5 |
0.049
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.049
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.048
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.048
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.048
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.047
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.047
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.047
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.047
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.047
|
Human Mouse |
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.047
|
Mouse |
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.047
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.047
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.047
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.047
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.046
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.046
|
Human |
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.046
|
Human |
|
|
maintenance of location
|
GO:0051235 |
89 |
0.046
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.046
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.046
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.046
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.045
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.045
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.045
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.044
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.044
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.044
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.044
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.044
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.044
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.044
|
Human Mouse |
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.044
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.043
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.043
|
|
|
|
locomotion involved in locomotory behavior
|
GO:0031987 |
8 |
0.043
|
|
|
|
mating
|
GO:0007618 |
27 |
0.043
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.043
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.042
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.042
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.042
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.042
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.042
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.042
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.042
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.042
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.041
|
|
|
|
regulation of catecholamine metabolic process
|
GO:0042069 |
10 |
0.041
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.041
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.041
|
Human |
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.041
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.041
|
Human |
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.040
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.040
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.040
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.040
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.039
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.039
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.039
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.039
|
Mouse |
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.039
|
Human |
|
|
neural crest cell migration involved in autonomic nervous system development
|
GO:1901166 |
5 |
0.039
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.039
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.039
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.039
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.039
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.038
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.038
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.038
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.038
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.038
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.038
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.037
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.037
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.037
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.037
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.036
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.036
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.036
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.036
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.036
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.036
|
|
|
|
positive regulation of catecholamine metabolic process
|
GO:0045915 |
2 |
0.035
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.035
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.035
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.035
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.035
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.035
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.034
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.034
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.034
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.034
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.034
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.034
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.034
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.034
|
Mouse |
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.034
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.034
|
|
|
|
facial nerve structural organization
|
GO:0021612 |
10 |
0.034
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.033
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.033
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.033
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
24 |
0.033
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.033
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.033
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.033
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.033
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.033
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.033
|
|
|
|
posterior midgut development
|
GO:0007497 |
1 |
0.032
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.032
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.032
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.032
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.032
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.032
|
Human |
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.032
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.031
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.031
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.031
|
Mouse |
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.031
|
Human |
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.031
|
Mouse |
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.031
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.031
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.031
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.031
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.031
|
Human |
|
|
phagocytosis
|
GO:0006909 |
66 |
0.031
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.031
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.031
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.031
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.030
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.030
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.030
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.030
|
|
|
|
negative regulation of cyclic nucleotide biosynthetic process
|
GO:0030803 |
5 |
0.030
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.030
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.030
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.030
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.030
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.030
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.029
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.029
|
Human |
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.029
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.029
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.029
|
Mouse |
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.029
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.029
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.029
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.029
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.029
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.029
|
Human |
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.029
|
|
|
|
venous blood vessel development
|
GO:0060841 |
13 |
0.029
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.028
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.028
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.028
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.028
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.028
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.028
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.028
|
Human |
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.028
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.028
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.028
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.028
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.028
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.027
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.027
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.027
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.027
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.027
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.027
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.027
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.027
|
Human Mouse |
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.027
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.027
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.027
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.026
|
Mouse |
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.026
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
Human |
|
|
cartilage development
|
GO:0051216 |
140 |
0.026
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.026
|
Human |
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.026
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.026
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.026
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.026
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.026
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.026
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.026
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.026
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.026
|
Human |
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.025
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.025
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.025
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.025
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.025
|
|
|
|
copulation
|
GO:0007620 |
7 |
0.025
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.025
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.025
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.025
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.025
|
|
|
|
heat generation
|
GO:0031649 |
13 |
0.025
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.025
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.024
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.024
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.024
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.024
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.024
|
|
|
|
detection of chemical stimulus involved in sensory perception of pain
|
GO:0050968 |
3 |
0.024
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.024
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.024
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.024
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.024
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.024
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.024
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.024
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.024
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.023
|
|
|
|
regulation of urine volume
|
GO:0035809 |
6 |
0.023
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.023
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.023
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.023
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.023
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.023
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.023
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.023
|
Human |
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.023
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.023
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.023
|
Human Mouse |
